Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.

Yi A, Cho N, Im SA, Chang JM, Kim SJ, Moon HG, Han W, Park IA, Noh DY, Moon WK.

Radiology. 2013 Sep;268(3):662-72. doi: 10.1148/radiol.13121801. Epub 2013 Apr 16.

PMID:
23592770
[PubMed - indexed for MEDLINE]
2.

Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.

Li SP, Makris A, Beresford MJ, Taylor NJ, Ah-See ML, Stirling JJ, d'Arcy JA, Collins DJ, Kozarski R, Padhani AR.

Radiology. 2011 Jul;260(1):68-78. doi: 10.1148/radiol.11102493. Epub 2011 Apr 18.

PMID:
21502383
[PubMed - indexed for MEDLINE]
3.

Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.

Kim SA, Cho N, Ryu EB, Seo M, Bae MS, Chang JM, Moon WK.

Radiology. 2014 Mar;270(3):699-707. doi: 10.1148/radiol.13130459. Epub 2013 Oct 28.

PMID:
24126372
[PubMed - indexed for MEDLINE]
4.

Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.

Tateishi U, Miyake M, Nagaoka T, Terauchi T, Kubota K, Kinoshita T, Daisaki H, Macapinlac HA.

Radiology. 2012 Apr;263(1):53-63. doi: 10.1148/radiol.12111177.

PMID:
22438441
[PubMed - indexed for MEDLINE]
5.

Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.

Ei Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ, Bluemke DA.

Radiology. 2010 Jul;256(1):64-73. doi: 10.1148/radiol.10091367.

PMID:
20574085
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.

Park SH, Moon WK, Cho N, Song IC, Chang JM, Park IA, Han W, Noh DY.

Radiology. 2010 Oct;257(1):56-63. doi: 10.1148/radiol.10092021.

PMID:
20851939
[PubMed - indexed for MEDLINE]
7.

Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.

Li SP, Taylor NJ, Makris A, Ah-See ML, Beresford MJ, Stirling JJ, d'Arcy JA, Collins DJ, Padhani AR.

Radiology. 2010 Dec;257(3):643-52. doi: 10.1148/radiol.10100421. Epub 2010 Sep 21.

PMID:
20858850
[PubMed - indexed for MEDLINE]
8.

Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics.

Millet I, Curros-Doyon F, Molinari N, Bouic-Pages E, Prat X, Alili C, Taourel P.

Radiology. 2014 Jan;270(1):57-66. doi: 10.1148/radiol.13122758. Epub 2013 Oct 28.

PMID:
24029641
[PubMed - indexed for MEDLINE]
9.

Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.

Wieder HA, Rosenberg R, Lordick F, Geinitz H, Beer A, Becker K, Woertler K, Dobritz M, Siewert JR, Rummeny EJ, Stollfuss JC.

Radiology. 2007 Jun;243(3):744-51. Epub 2007 Apr 26.

PMID:
17463134
[PubMed - indexed for MEDLINE]
10.

Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.

Li KL, Partridge SC, Joe BN, Gibbs JE, Lu Y, Esserman LJ, Hylton NM.

Radiology. 2008 Jul;248(1):79-87. doi: 10.1148/radiol.2481070846.

PMID:
18566170
[PubMed - indexed for MEDLINE]
11.

Contralateral lesions detected by preoperative MRI in patients with recently diagnosed breast cancer: application of MR CAD in differentiation of benign and malignant lesions.

Cho N, Kim SM, Park JS, Jang M, Kim SY, Chang JM, Moon WK.

Eur J Radiol. 2012 Jul;81(7):1520-6. doi: 10.1016/j.ejrad.2011.03.060. Epub 2011 Apr 16.

PMID:
21498016
[PubMed - indexed for MEDLINE]
12.

Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.

Heldahl MG, Bathen TF, Rydland J, Kvistad KA, Lundgren S, Gribbestad IS, Goa PE.

Acta Radiol. 2010 Jul;51(6):604-12. doi: 10.3109/02841851003782059.

PMID:
20429756
[PubMed - indexed for MEDLINE]
13.

Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation.

Chen JH, Nie K, Bahri S, Hsu CC, Hsu FT, Shih HN, Lin M, Nalcioglu O, Su MY.

Radiology. 2010 Apr;255(1):44-52. doi: 10.1148/radiol.09091090.

PMID:
20308443
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.

Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.

Radiology. 2007 Jun;243(3):670-80. Epub 2007 Apr 19.

PMID:
17446524
[PubMed - indexed for MEDLINE]
15.

Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet.

Calabrese M, Brizzi D, Carbonaro L, Chiaramondia M, Kirchin MA, Sardanelli F.

Radiol Med. 2009 Mar;114(2):267-85. doi: 10.1007/s11547-008-0358-2. Epub 2009 Feb 4. English, Italian.

PMID:
19194774
[PubMed - indexed for MEDLINE]
16.

Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.

Williams TC, DeMartini WB, Partridge SC, Peacock S, Lehman CD.

Radiology. 2007 Jul;244(1):94-103. Epub 2007 May 16.

PMID:
17507720
[PubMed - indexed for MEDLINE]
17.

Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.

Abramson RG, Li X, Hoyt TL, Su PF, Arlinghaus LR, Wilson KJ, Abramson VG, Chakravarthy AB, Yankeelov TE.

Magn Reson Imaging. 2013 Nov;31(9):1457-64. doi: 10.1016/j.mri.2013.07.002. Epub 2013 Aug 15.

PMID:
23954320
[PubMed - indexed for MEDLINE]
18.

Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.

Manfredi R, Frulloni L, Mantovani W, Bonatti M, Graziani R, Pozzi Mucelli R.

Radiology. 2011 Aug;260(2):428-36. doi: 10.1148/radiol.11101729. Epub 2011 May 25.

PMID:
21613442
[PubMed - indexed for MEDLINE]
19.

Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients.

Tuncbilek N, Tokatli F, Altaner S, Sezer A, Türe M, Omurlu IK, Temizoz O.

Eur J Radiol. 2012 May;81(5):863-7. doi: 10.1016/j.ejrad.2011.02.021. Epub 2011 Mar 12.

PMID:
21398061
[PubMed - indexed for MEDLINE]
20.

Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy.

Pickles MD, Manton DJ, Lowry M, Turnbull LW.

Eur J Radiol. 2009 Sep;71(3):498-505. doi: 10.1016/j.ejrad.2008.05.007. Epub 2008 Jun 24.

PMID:
18572340
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk